CareDx, Inc., headquartered in Brisbane, California, is a global molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions for transplant patients. CareDx offers testing products across transplantation, including AlloMap® and AlloSure™ for post-transplant surveillance and Olerup SSP®, XM-ONE®, QTYPE®, Gamma-Type™ and SBT Resolver™ in pre-transplant testing. Additional information is available at www.caredx.com.